Axsome Therapeutics announces closing of $9.5 million registered direct offering
Axsome Therapeutics announced the closing of its previously announced registered direct offering. Axsome sold 1,783,587 shares of its common stock and warrants to purchase up to an aggregate of 1,783,587 shares of its common stock at a combined purchase price of $5.325 per share and related warrant. December 06, 2017